Document Classification

Section Type: RESULTS

Text: Orlistat treatment caused a greater improvement in glycemic control than placebo, as evidenced by a greater reduction in serum HbA (1c), adjusted for changes in metformin and sulfonylurea therapy (-0. 90 + / - 0. 08 vs. -0. 61 + / - 0. 08, P = 0. 014) ; a greater proportion of patients achieving decreases in HbA (1c) of > or = 0. 5 and > or = 1. 0 % (both P < 0. 01) ; and a greater reduction in fasting serum glucose (-2. 0 + / - 0. 2 vs. -0. 7 + / - 0. 2 mmol/l, P = 0. 001).